Transnational Health Economic Policy Development: Study of East Asian and Pacific countries
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: ABRAHAM, Ivo (UNIVERSITY OF ARIZONA, Pharmacy Practice and Science, Tucson, United States)
- Co-author(s): Preshit Ambade:College of Public Health,UNIVERSITY OF ARIZONA,Tucson,United States|Chinmayee Katragadda:Center for Health Outcomes and PharmacoEconomic Research,UNIVERSITY OF ARIZONA,Tucson,United States|Diana Sun:,Genentech,San Francisco,United States|Ivo Abraham:Center for Health Outcomes and PharmacoEconomic Research,UNIVERSITY OF ARIZONA,Tucson,United States
National-supranational level pharmacoeconomic policy formulation process often impedes access to pharamacotherapeutics innovations undermining similarities-dissimilarities in terms of health indicators between the nations even though pharmaceutical expenditure forms significant proportion of the total health expenditure for these countries.
Our.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.